Particle Counters Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Particle Counters market is expected to register a 9.5% of CAGR over the forecast period. Manufacturing of pharmaceutical products may involve a lot of risk at contamination. Fungal contamination is one of the major type of contamination. This can lead to reduced product integrity and shelf life. The main reason is lack of quality control, process control and proper testing. This can be present in the form of bioaerosols and hence requires monitoring of these facilities. Furthermore, the technological advancements related to the product are expected to drive the market growth. In 2020, Particle Measuring Systems developed a 20nm syringe sampler “SLS” which will be used in batch sampling with the particle counter “ Chem 20 Particle Counter”. Therefore, these factors are expected to fuel the particle counter market growth.

Key Market Trends

Portable Segment is Expected to Exhibhit a Significant Market Growth in the Particle Counters Market

Portable counter is expected to show a significant growth rate in the particle counter, owing to the increasing product recalls and new upcoming products. According to the International Journal of Environmental Research and Public Health’s published study, around 40 medications are recalled per year in the United States and South Korea.

Furthermore, in 2019, Lighthouse introduced a ApexZ3 and Z50 portable Airborne Particle Counters in the market. It’s one of the lightest and smallest 100 LPM particle counter based on self-diagnostics technology that enables the accuracy of the data. Thus, the aforementioned factors are expected to impact positively on the market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Particle Counters market owing to due to increasing investment in research development activities related to pharmaceuticals and biopharmaceuticals. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA), United States has highest share of around 58% in terms of R&D expenditure. Furthermore, the research and development expenditure by biopharmaceutical companies was accounted for around 79.6 billion USD in 2018. Thus, it is expected to impact positively on the particle counter market.

Competitive Landscape

Key players that are operating in the Particle Counters market include Danaher Corporation, Markus Klotz GmbH, PAMAS Partikelmess- und Analysesysteme GmbH, Rion Co. Ltd., Merck KGaA, Olympus Corporation, HAL Technology, Fluke Corporation, Setra Systems and Spectris.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support